Not applicableUnknownNCT06171100What this trial is testingLow-dose Tolvaptan for Inpatient Hyponatraemia.Who this might be right forHyponatremiaSIADH King's College Hospital NHS Trust 180
Not applicableUnknownNCT01509170What this trial is testingThe Clinical and Laboratory Characteristics of Recurrent Drug- Related HyponatremiaWho this might be right forHyponatremiaSIADH Hadassah Medical Organization 500
Large-scale testing (Phase 3)Ended earlyNCT00728091What this trial is testingA Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional HyponatremiaWho this might be right forHyponatremiaInappropriate ADH Syndrome Sanofi 2
Not applicableStudy completedNCT01056848What this trial is testingInternational, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430Who this might be right forHyponatremia With Normal Extracellular Fluid VolumeHyponatremia With Excess Extracellular Fluid Volume CardioKine Inc. 135
Post-approval studies (Phase 4)WithdrawnNCT00298753What this trial is testingUrinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic MedicineWho this might be right forSyndrome of Inappropriate ADH-secretion Regional Hospital Holstebro
Not applicableLooking for participantsNCT06065852What this trial is testingNational Registry of Rare Kidney DiseasesWho this might be right forAdenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more UK Kidney Association 35,000
Large-scale testing (Phase 3)Study completedNCT02874807What this trial is testingEffects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND StudyWho this might be right forSIADH University Hospital, Basel, Switzerland 88
Not applicableStudy completedNCT06277336What this trial is testingEffects of Intravenous [Pyr1]Apelin-13 on Healthy Volunteers With Artificially Induced SIADWho this might be right forSIAD - Syndrome of Inappropriate AntidiuresisHyponatremia University Hospital, Basel, Switzerland 15
Large-scale testing (Phase 3)Ended earlyNCT01227512What this trial is testingEffects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional HyponatremiaWho this might be right forHyponatremiaDilutional HyponatremiaInappropriate ADH Syndrome Otsuka Pharmaceutical Development & Commercialization, Inc. 124
Large-scale testing (Phase 3)Study completedNCT00264914What this trial is testingSafety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionWho this might be right forInappropriate ADH SyndromeHyponatremia Sanofi 57
Not applicableWithdrawnNCT01425125What this trial is testingFractional Urate Excretion in Nonedematous HyponatremiaWho this might be right forCerebral HyponatremiaSIADHCerebral Salt-wasting Syndrome+1 more NYU Langone Health
Not applicableStudy completedNCT01341665What this trial is testingSubclassification of the Syndrome of Inappropriate ADH SecretionWho this might be right forHyponatremia University of Wuerzburg 50
Large-scale testing (Phase 3)Study completedNCT00072683What this trial is testing"SALT Trial" Study of Ascending Levels of Tolvaptan in HyponatremiaWho this might be right forHyponatremiasWater IntoxicationInappropriate ADH Syndrome+1 more Otsuka Pharmaceutical Development & Commercialization, Inc. 240
Not applicableEnded earlyNCT02545114What this trial is testingTolvaptan for Patients With Acute Neurological InjuriesWho this might be right forHyponatremiaSIADH Polderman, Kees, H., MD, PhD 25
Testing effectiveness (Phase 2)Study completedNCT02009878What this trial is testingA PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)Who this might be right forSyndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Large-scale testing (Phase 3)Study completedNCT00201994What this trial is testing"SALT-2 Trial" Study of Ascending Levels of Tolvaptan in HyponatremiaWho this might be right forHyponatremiaWater IntoxicationInappropriate ADH Syndrome+1 more Otsuka Pharmaceutical Development & Commercialization, Inc. 243
Not applicableStudy completedNCT02545101What this trial is testingAn Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADHWho this might be right forHyponatremiaSyndrome of Inappropriate ADH (SIADH) Secretion Otsuka Pharmaceutical Europe Ltd 100
Large-scale testing (Phase 3)Study completedNCT03048747What this trial is testingTrial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADHWho this might be right forSyndrome of Inappropriate Antidiuretic Hormone Secretion Otsuka Pharmaceutical Co., Ltd. 16
Not applicableLooking for participantsNCT07528365What this trial is testingUrea for Treatment of Hyponatremia in Patients With SIAD Unresponsive to Fluid RestrictionWho this might be right forSIAD - Syndrome of Inappropriate Antidiuresis University of Turin, Italy 20
Not applicableStudy completedNCT02573077What this trial is testingAn Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in ItalyWho this might be right forHyponatremiaSyndrome of Inappropriate ADH (SIADH) SecretionCancer Otsuka Pharmaceutical Europe Ltd 69